TicAgrelor Versus CLOpidogrel in Stabilized Patients With Acute Myocardial Infarction: TALOS-AMI
Status:
Completed
Trial end date:
2021-01-21
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of clopidogrel in stabilized
patients with acute myocardial infarction (AMI) who performed percutaneous coronary
intervention (PCI) with drug-eluting stents (DES) compared with ticagrelor.
In this study, 2,590 patients with AMI who underwent PCI with DES and took dual antiplatelet
therapy as aspirin and ticagrelor during 1 month from index PCI will be randomized to
aspirin+ticagrelor versus aspirin+ clopidogrel during 11 months.